Home

Sukumar Nagendran, President and Head of R&D: Taysha Gene Therapies TSHA Sell · Filed 04/13

Trade details

Type
Insider sale
Amount
$892,000
Shares · price
200,000 sh · $4.46 a share
Held after
1,136,410 sh
Trade date
26/04/10
Filed
26/04/13
Days to filing
3 days

Sold 15.0% of holdings

Share of holding sold
15.0%

Taysha Gene Therapies trades, last 26 weeks

What else happened in Taysha Gene Therapies around then

Filed or reported within 30 days of the trade day · 03/11~05/10

Sukumar Nagendran's recent trades

  • Sukumar Nagendran

    Planned sale10b5-1 planTaysha Gene Therapies

    $1.3M

    Filed 07/10

  • Sukumar Nagendran

    Planned sale10b5-1 planTaysha Gene Therapies

    $926K

    Filed 04/10

  • Sukumar Nagendran

    SellTaysha Gene Therapies

    $423.4K

    Filed 01/27

  • Sukumar Nagendran

    SellTaysha Gene Therapies

    $124.1K

    Filed 01/27

  • Sukumar Nagendran

    Planned saleTaysha Gene Therapies

    $579.4K

    Filed 01/23